AR070919A1 - (pirazolilcarbonil) imidazolidinonas sustituidas y su uso - Google Patents
(pirazolilcarbonil) imidazolidinonas sustituidas y su usoInfo
- Publication number
- AR070919A1 AR070919A1 ARP090100947A ARP090100947A AR070919A1 AR 070919 A1 AR070919 A1 AR 070919A1 AR P090100947 A ARP090100947 A AR P090100947A AR P090100947 A ARP090100947 A AR P090100947A AR 070919 A1 AR070919 A1 AR 070919A1
- Authority
- AR
- Argentina
- Prior art keywords
- alkoxy
- cyano
- halogen
- hydroxy
- substituted
- Prior art date
Links
- 150000008624 imidazolidinones Chemical class 0.000 title 1
- 125000000229 (C1-C4)alkoxy group Chemical group 0.000 abstract 8
- 229910052736 halogen Inorganic materials 0.000 abstract 6
- 150000002367 halogens Chemical class 0.000 abstract 6
- 125000004178 (C1-C4) alkyl group Chemical group 0.000 abstract 5
- 125000004093 cyano group Chemical group *C#N 0.000 abstract 4
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 4
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 4
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 abstract 4
- 125000001424 substituent group Chemical group 0.000 abstract 4
- 201000010099 disease Diseases 0.000 abstract 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 3
- 125000000876 trifluoromethoxy group Chemical group FC(F)(F)O* 0.000 abstract 3
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 abstract 3
- 125000006272 (C3-C7) cycloalkyl group Chemical group 0.000 abstract 2
- 125000003282 alkyl amino group Chemical group 0.000 abstract 2
- -1 cyano, hydroxy Chemical group 0.000 abstract 2
- 125000000753 cycloalkyl group Chemical group 0.000 abstract 2
- 125000000623 heterocyclic group Chemical group 0.000 abstract 2
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 abstract 2
- 125000004043 oxo group Chemical group O=* 0.000 abstract 2
- 238000011321 prophylaxis Methods 0.000 abstract 2
- 150000003839 salts Chemical class 0.000 abstract 2
- 239000012453 solvate Substances 0.000 abstract 2
- 238000011282 treatment Methods 0.000 abstract 2
- 125000005034 trifluormethylthio group Chemical group FC(S*)(F)F 0.000 abstract 2
- 241001465754 Metazoa Species 0.000 abstract 1
- 125000000217 alkyl group Chemical group 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 230000001177 retroviral effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Virology (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Health & Medical Sciences (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Molecular Biology (AREA)
- AIDS & HIV (AREA)
- Tropical Medicine & Parasitology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Compuesto de formula (1) en donde R1 representa fenilo, estando dicho fenilo sustituido con entre 1 y 3 sustituyentes, los sustituyentes se seleccionan en forma independiente entre sí del grupo formado por halogeno, hidroxi, ciano, nitro, trifluoro metilo trifluorometoxi, trifluorometiltio, alquilo C1-4 y alcoxi C1-4, en donde alquilo C1-4 y alcoxi C1-4 pueden a su vez estar sustituidos entre una y tres veces, de manera idéntica o diferente, con radicales seleccionados entre la serie halogeno, ciano, hidroxi, alcoxi C1-4, amino, monoalquilamino C1-4, di-alquilamino C1-4, cicloalquilo C3-7 y heterociclilo de 4 a 7 miembros, pudiendo los radicales cicloalquilo y heterociclilo mencionados en ultimo término estar cada uno a su vez sustituido hasta tres veces, de manera idéntica o diferente, con halogeno, ciano, alquilo C1-4, trifluorometilo, hidroxi, alcoxi C1-4, trifluorometoxi, oxo, amino, monoalquilamino C1-4 y di-alquilamino C1-4, R2 representa fenilo, estando dicho fenilo sustituido con entre 1 y 3 sustituyentes, y los sustituyentes se seleccionan en forma independiente entre sí del grupo formado por halogeno, hidroxi, ciano, nitro, trifluorometilo, trifluorometoxi, trifluorometiltio, alquilo C1-4 y alcoxi C1-4, en donde alquilo C1-4 y alcoxi C1-4 pueden a su vez estar sustituidos entre una y tres veces, de manera idéntica o diferente, con radicales seleccionados entre la serie halogeno, ciano, hidroxi, alcoxi C1-4, amino, monoalquilamino C1-4, di-alquilamino C1-4, cicloalquilo C3-7 y heterociclilo de 4 a 7 miembros, pudiendo los radicales cicloalquilo y heterociclilo mencionados en ultimo término estar cada uno a su vez sustituido hasta tres veces, de manera idéntica o diferente, con halogeno, ciano, alquilo C1-4, trifluorometilo, hidroxi, alcoxi C1-4, trifluorometoxi, oxo, amino, monoalquilamino C1-4 y di-alquilamino C1-4, o una de las sales del mismo, los solvatos del mismo o los solvatos de las sales del mismo. Métodos para su preparacion, su uso para el tratamiento y/o la profilaxis de enfermedades, así como su uso para la preparacion de medicamentos para el tratamiento y/o la profilaxis de enfermedades, especialmente de enfermedades retrovirales, en humanos y/o animales.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE102008015033A DE102008015033A1 (de) | 2008-03-17 | 2008-03-17 | Substituierte (Pyrazolyl-carbonyl)imidazolidinone und ihre Verwendung |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR070919A1 true AR070919A1 (es) | 2010-05-12 |
Family
ID=40565083
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP090100947A AR070919A1 (es) | 2008-03-17 | 2009-03-17 | (pirazolilcarbonil) imidazolidinonas sustituidas y su uso |
Country Status (22)
| Country | Link |
|---|---|
| US (1) | US8399682B2 (es) |
| EP (1) | EP2254885B1 (es) |
| JP (1) | JP5576853B2 (es) |
| KR (1) | KR20100124337A (es) |
| CN (1) | CN101977908B (es) |
| AP (1) | AP2774A (es) |
| AR (1) | AR070919A1 (es) |
| AU (1) | AU2009226656A1 (es) |
| CA (1) | CA2718685C (es) |
| CL (1) | CL2009000636A1 (es) |
| DE (1) | DE102008015033A1 (es) |
| IL (1) | IL207649A0 (es) |
| MA (1) | MA32224B1 (es) |
| MX (1) | MX2010010230A (es) |
| NZ (1) | NZ588141A (es) |
| PE (1) | PE20091718A1 (es) |
| RU (1) | RU2010141578A (es) |
| TW (1) | TW200951125A (es) |
| UA (1) | UA102390C2 (es) |
| UY (1) | UY31717A1 (es) |
| WO (1) | WO2009115213A1 (es) |
| ZA (1) | ZA201007361B (es) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE102008015033A1 (de) | 2008-03-17 | 2009-09-24 | Aicuris Gmbh & Co. Kg | Substituierte (Pyrazolyl-carbonyl)imidazolidinone und ihre Verwendung |
| DE102008015032A1 (de) * | 2008-03-17 | 2009-09-24 | Aicuris Gmbh & Co. Kg | Substituierte Pyrazolamide und ihre Verwendung |
| DE102008062863A1 (de) | 2008-12-17 | 2010-06-24 | Aicuris Gmbh & Co. Kg | Substituierte (Thiophenyl-carbonyl)imidazolidinone und ihre Verwendung |
| DE102008062878A1 (de) | 2008-12-17 | 2010-06-24 | Aicuris Gmbh & Co. Kg | Substituierte Furancarboxamide und ihre Verwendung |
| EP2295038B1 (en) * | 2009-09-11 | 2013-05-29 | AiCuris GmbH & Co. KG | Solid dispersion comprising an anti-HIV agent |
| DE102011055815A1 (de) | 2011-11-29 | 2013-05-29 | Aicuris Gmbh & Co. Kg | Carboxamid-substituierte Heteroaryl-Pyrazole und ihre Verwendung |
| DE102012016908A1 (de) | 2012-08-17 | 2014-02-20 | Aicuris Gmbh & Co. Kg | Tris-(Hetero)Aryl-Pyrazole und ihre Verwendung |
Family Cites Families (50)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB453061A (en) | 1935-03-23 | 1936-09-04 | Charles Howard Twigg | Improvements in and relating to gas heated geysers and water heaters |
| US3806506A (en) | 1971-08-05 | 1974-04-23 | Uniroyal Inc | Furan derivatives,compositions thereof and methods for using same |
| DE3119796A1 (de) | 1981-05-19 | 1982-12-23 | Hoechst Ag, 6000 Frankfurt | Substituierte tryptaminderivate von thienyloxpropanolaminen, verfahren zu ihrer herstellung, pharmazeutische praeparate auf basis dieser verbindungen sowie ihre verwendung |
| FR2538388B1 (fr) | 1982-12-24 | 1985-06-21 | Pharmuka Lab | Nouveaux derives de naphtalene- ou azanaphtalenecarboxamide, leurs procedes de preparation et leur utilisation comme medicaments |
| US5591761A (en) | 1993-05-20 | 1997-01-07 | Texas Biotechnology Corporation | Thiophenyl-, furyl-and pyrrolyl-sulfonamides and derivatives thereof that modulate the activity of endothelin |
| PH27357A (en) | 1989-09-22 | 1993-06-21 | Fujisawa Pharmaceutical Co | Pyrazole derivatives and pharmaceutical compositions comprising the same |
| US5571810A (en) | 1990-06-11 | 1996-11-05 | Fujisawa Pharmaceutical Co., Ltd. | Thiophene derivatives |
| GB9012936D0 (en) | 1990-06-11 | 1990-08-01 | Fujisawa Pharmaceutical Co | Thiophene derivatives,processes for preparation thereof and pharmaceutical composition comprising the same |
| IL104311A (en) | 1992-02-05 | 1997-07-13 | Fujisawa Pharmaceutical Co | Pyrazole derivatives, processes for the preparation thereof and pharmaceutical compositions containing the same |
| FR2692575B1 (fr) | 1992-06-23 | 1995-06-30 | Sanofi Elf | Nouveaux derives du pyrazole, procede pour leur preparation et compositions pharmaceutiques les contenant. |
| JPH084281B2 (ja) | 1992-09-30 | 1996-01-17 | 橋本コーポレイション株式会社 | オンフック後相手の声を拡声する電話装置 |
| FR2728571B1 (fr) | 1994-12-22 | 1997-01-31 | Adir | Nouveaux ethers d'oximes tricycliques, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent |
| US5696151A (en) | 1995-11-30 | 1997-12-09 | Uniroyal Chemical Company, Inc. | Compounds useful for the inhibition of the replication of HIV-1 and HIV-1 mutants |
| US6143780A (en) | 1999-09-17 | 2000-11-07 | Uniroyal Chemical Company, Inc. | N-arylmethylthioanilide compounds useful for the inhibition of the replication of HIV |
| EP1299381B1 (en) | 2000-06-28 | 2008-05-07 | AstraZeneca AB | Substituted quinazoline derivatives and their use as inhibitors |
| GB0113524D0 (en) * | 2001-06-04 | 2001-07-25 | Hoffmann La Roche | Pyrazole derivatives |
| JP2005501841A (ja) | 2001-08-01 | 2005-01-20 | バセル ポリオレフィン ジーエムビーエイチ | 複素環式ペンタレン誘導体の製造方法 |
| EP1451160B1 (en) | 2001-11-01 | 2010-01-13 | Icagen, Inc. | Pyrazole-amides for use in the treatment of pain |
| US7005432B2 (en) | 2002-05-16 | 2006-02-28 | Hoffman-La Roche Inc. | Substituted imidazol-pyridazine derivatives |
| EP1534680B1 (en) | 2002-08-14 | 2012-02-22 | Pharmaco Investments, Inc. | Prenylation inhibitors and methods of their synthesis and use |
| GB0221477D0 (en) * | 2002-09-16 | 2002-10-23 | Pfizer Ltd | Chemical compounds |
| GB0223232D0 (en) * | 2002-10-07 | 2002-11-13 | Pfizer Ltd | Chemical compounds |
| MXPA05005742A (es) | 2002-12-02 | 2005-08-16 | Astellas Pharma Inc | Derivados de pirazol utiles como inhibidores de cox-i. |
| WO2004069824A1 (ja) | 2003-02-07 | 2004-08-19 | Daiichi Pharmaceutical Co., Ltd. | ピラゾール誘導体 |
| TW200423930A (en) * | 2003-02-18 | 2004-11-16 | Hoffmann La Roche | Non-nucleoside reverse transcriptase inhibitors |
| MXPA05006861A (es) | 2003-02-27 | 2005-12-12 | Neurosearch As | Derivados arildiazabiciclicos novedosos. |
| FR2856683A1 (fr) | 2003-06-25 | 2004-12-31 | Sanofi Synthelabo | Derives de 4-cyanopyrazole-3-carboxamide, leur preparation et leur application en therapeutique |
| HRP20110757T1 (hr) * | 2003-06-26 | 2011-11-30 | Novartis Ag | Inhibitori kinaze p38 bazirani na 5-članom heterociklu |
| GB0315657D0 (en) * | 2003-07-03 | 2003-08-13 | Astex Technology Ltd | Pharmaceutical compounds |
| US20050026968A1 (en) | 2003-07-14 | 2005-02-03 | University Of Tennessee Research Foundation | Heterocyclic amides with anti-tuberculosis activity |
| US7220772B2 (en) * | 2003-09-05 | 2007-05-22 | Pfizer, Inc. | Pyrazole derivatives |
| FR2860792B1 (fr) | 2003-10-10 | 2006-02-24 | Sanofi Synthelabo | Derives de thiophene-2-carboxamide, leur preparation et leur application en therapeutique |
| JP4208925B2 (ja) | 2004-02-20 | 2009-01-14 | アストラゼネカ アクチボラグ | 治療薬 |
| AU2005258397A1 (en) | 2004-07-01 | 2006-01-12 | Daiichi Pharmaceutical Co., Ltd. | Pyrazole derivatives |
| GB0417910D0 (en) | 2004-08-11 | 2004-09-15 | Novartis Ag | Organic compounds |
| JP4942654B2 (ja) | 2004-08-23 | 2012-05-30 | イーライ リリー アンド カンパニー | ヒスタミンｈ３受容体薬剤、製剤及び治療的使用 |
| DE102004054666A1 (de) | 2004-11-12 | 2006-05-18 | Bayer Cropscience Gmbh | Substituierte Pyrazol-3-carboxamide, Verfahren zur Herstellung und Verwendung als Herbizide und Pflanzenwachstumsregulatoren |
| US7741479B2 (en) | 2004-12-07 | 2010-06-22 | Locus Pharmaceuticals, Inc. | Urea inhibitors of MAP kinases |
| US7612200B2 (en) | 2004-12-07 | 2009-11-03 | Locus Pharmaceuticals, Inc. | Inhibitors of protein kinases |
| MX2007006743A (es) | 2004-12-15 | 2007-07-09 | Astrazeneca Ab | Ligandos del receptor de acetilcolina nicotinica. |
| GT200600105A (es) | 2005-03-10 | 2007-02-14 | Derivados de pirimidina para el tratamiento de trastornos hiperproliferativos. | |
| EP1910307A1 (en) | 2005-06-27 | 2008-04-16 | Exelixis, Inc. | Pyrazole based lxr modulators |
| ES2326723B1 (es) | 2005-07-15 | 2010-05-11 | Laboratorios Del Dr. Esteve, S.A. | Uso de compuestos de pirazol sustituidos y combinaciones de los mismos para el tratamiento del sindrome metabolico. |
| EP1743637A1 (en) | 2005-07-15 | 2007-01-17 | Laboratorios Del Dr. Esteve, S.A. | Use of substituted pyrazole compounds and combinations thereof for the treatment of the metabolic syndrome |
| GB0516661D0 (en) | 2005-08-13 | 2005-09-21 | Astrazeneca Ab | Therapeutic agents |
| DE602007004881D1 (de) | 2006-10-12 | 2010-04-01 | Janssen Pharmaceutica Nv | Substituierte pyrazinonderivate zur verwendung als arzneimittel |
| EP2518063B1 (en) | 2006-12-21 | 2017-02-01 | Sloan-Kettering Institute For Cancer Research | Pyridazinones and furan-containing compounds |
| GB0701426D0 (en) | 2007-01-25 | 2007-03-07 | Univ Sheffield | Compounds and their use |
| DE102008015033A1 (de) | 2008-03-17 | 2009-09-24 | Aicuris Gmbh & Co. Kg | Substituierte (Pyrazolyl-carbonyl)imidazolidinone und ihre Verwendung |
| DE102008015032A1 (de) * | 2008-03-17 | 2009-09-24 | Aicuris Gmbh & Co. Kg | Substituierte Pyrazolamide und ihre Verwendung |
-
2008
- 2008-03-17 DE DE102008015033A patent/DE102008015033A1/de not_active Ceased
-
2009
- 2009-03-10 WO PCT/EP2009/001714 patent/WO2009115213A1/de not_active Ceased
- 2009-03-10 AP AP2010005422A patent/AP2774A/xx active
- 2009-03-10 NZ NZ588141A patent/NZ588141A/en not_active IP Right Cessation
- 2009-03-10 AU AU2009226656A patent/AU2009226656A1/en not_active Abandoned
- 2009-03-10 JP JP2011500075A patent/JP5576853B2/ja not_active Expired - Fee Related
- 2009-03-10 CA CA2718685A patent/CA2718685C/en not_active Expired - Fee Related
- 2009-03-10 RU RU2010141578/04A patent/RU2010141578A/ru not_active Application Discontinuation
- 2009-03-10 EP EP09721416.7A patent/EP2254885B1/de active Active
- 2009-03-10 MX MX2010010230A patent/MX2010010230A/es active IP Right Grant
- 2009-03-10 UA UAA201012130A patent/UA102390C2/ru unknown
- 2009-03-10 KR KR1020107023291A patent/KR20100124337A/ko not_active Withdrawn
- 2009-03-10 CN CN200980109500.6A patent/CN101977908B/zh not_active Expired - Fee Related
- 2009-03-16 TW TW098108355A patent/TW200951125A/zh unknown
- 2009-03-17 UY UY031717A patent/UY31717A1/es not_active Application Discontinuation
- 2009-03-17 PE PE2009000388A patent/PE20091718A1/es not_active Application Discontinuation
- 2009-03-17 CL CL2009000636A patent/CL2009000636A1/es unknown
- 2009-03-17 AR ARP090100947A patent/AR070919A1/es not_active Application Discontinuation
-
2010
- 2010-08-17 IL IL207649A patent/IL207649A0/en unknown
- 2010-09-17 US US12/885,340 patent/US8399682B2/en not_active Expired - Fee Related
- 2010-10-11 MA MA33241A patent/MA32224B1/fr unknown
- 2010-10-14 ZA ZA2010/07361A patent/ZA201007361B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| IL207649A0 (en) | 2010-12-30 |
| UA102390C2 (ru) | 2013-07-10 |
| AP2774A (en) | 2013-09-30 |
| JP2011514366A (ja) | 2011-05-06 |
| WO2009115213A1 (de) | 2009-09-24 |
| KR20100124337A (ko) | 2010-11-26 |
| RU2010141578A (ru) | 2012-04-27 |
| DE102008015033A1 (de) | 2009-09-24 |
| ZA201007361B (en) | 2011-12-28 |
| US8399682B2 (en) | 2013-03-19 |
| CL2009000636A1 (es) | 2010-05-07 |
| EP2254885A1 (de) | 2010-12-01 |
| AP2010005422A0 (en) | 2010-10-31 |
| CA2718685A1 (en) | 2009-09-24 |
| CN101977908B (zh) | 2014-04-23 |
| PE20091718A1 (es) | 2009-12-11 |
| UY31717A1 (es) | 2009-08-31 |
| CA2718685C (en) | 2016-11-29 |
| MA32224B1 (fr) | 2011-04-01 |
| US20110124618A1 (en) | 2011-05-26 |
| MX2010010230A (es) | 2010-11-09 |
| EP2254885B1 (de) | 2013-12-04 |
| CN101977908A (zh) | 2011-02-16 |
| AU2009226656A1 (en) | 2009-09-24 |
| JP5576853B2 (ja) | 2014-08-20 |
| NZ588141A (en) | 2012-05-25 |
| TW200951125A (en) | 2009-12-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY1124855T1 (el) | 2-(μορφολιν-4-υλ)-1,7-ναφθυριδινες | |
| AR070919A1 (es) | (pirazolilcarbonil) imidazolidinonas sustituidas y su uso | |
| AR069417A1 (es) | Piperidinas heteroaril - sustituidas | |
| UY29177A1 (es) | Derivados sustituidos de purina, purinona y deazapurina, composiciones que los contienen métodos para su preparación y sus usos | |
| UY34480A (es) | Compuestos de 2-(fenilo sustituido)-ciclopentan-1,3-diona y derivados de los mismos, composiciones y métodos para controlar malezas. | |
| PE20180508A1 (es) | Amidas heterociclicas como inhibidores de quinasa | |
| PE20170331A1 (es) | Derivados quinolina como inhibidores smo | |
| UY35675A (es) | Derivados sustituidos de quinazolin-4-ona | |
| PE20161066A1 (es) | Derivados de piperidinil-indol como inhibidores del factor de complemento b y usos de los mismos | |
| AR094997A1 (es) | Sales y formas sólidas de (s)-3-(4-((4-(morfolinometil)bencil)oxi)-1-oxoisoindolin-2-il)piperidin-2,6-diona y composiciones que las comprenden y sus usos | |
| AR067646A1 (es) | Ariloxazoles sustituidos y su uso | |
| CR20160123A (es) | Inhibidores de polimerasa hcv | |
| NI201600152A (es) | Compuestos de heteroarilo o arilo bicíclicos fusionados y su uso como inhibidores de irak4 | |
| CL2015000880A1 (es) | Compuestos heterociclicos derivados de 4-pirimidinona, inhibidores de la transcriptasa inversa del vih; composicion farmaceutica; uso en la profilaxis o el tratamiento de infeccion por vih o para la profilaxis, tratamiento o retraso de la aparicion del sida en un sujeto. | |
| CR20130680A (es) | Métodos plaguicidas que utilizan compuestos de 3-piridil tiazol sustituido y derivados para combatir las plagas de animales i | |
| AR064454A1 (es) | Derivados de pirazol con efecto inhibitorio de fgfr, metodos para su sintesis, composicion farmaceutica que los comprende, un proceso para la preparacion de la misma y su uso en la fabricacion de un medicamento para el tratamiento del cancer. | |
| CR20140045A (es) | Compuestos de n-tio-antranilamida y sus usos como plaguicidas | |
| CO2018003367A2 (es) | Benzamidas sustituidas con isoxazolina y análogos como insecticidas | |
| CU24411B1 (es) | Compuesto derivado de benzamida sustituida con 1,3-tiazol-2-ilo útil para el tratamiento de trastornos neurogénicos | |
| UY32916A (es) | Nuevas pirimidinas, sus sales farmacéuticamente aceptables, composiciones conteniéndolas y aplicaciones | |
| DOP2014000133A (es) | Triazolopiridinas sustituidas | |
| PE20151429A1 (es) | Dihidropirimidinonas biciclicas sustituidas y su uso como inhibidores de la actividad de elastasa neutrofilica | |
| ECSP13012596A (es) | Proceso de elaboración para derivados de pirimidina | |
| UY36145A (es) | Compuestos de 1, 3, 4-tiadiazol y uso de los mismos para el tratamiento del cáncer | |
| MX2017015225A (es) | Inhibidores de la autotaxina y sus usos. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA | Abandonment or withdrawal |